In recent years, computational screening approaches have been developed to suggest protein sequences with reduced the overall immunogenicity. The simplest approaches focused solely on introducing point mutations to reduce the amount of CD4 + T-cell epitopes by applying well-established epitope prediction methods [17] [18] [19] . However, the suggested mutations can have a significant impact on the stability and function of the protein. Naïve approaches not considering the structural impact on the protein will inevitably produce inactive designs. More advanced methods therefore try to exclude potentially harmful mutations by predicting their impact with various metrics 20 . The most recent approaches simultaneous optimize the number of deleted epitopes as well as the stability of the protein approximated either using structural or simple sequence information 21, 22 .
Recent advances in statistical protein modeling now allow to accurately infer the tertiary structure [23] [24] [25] [26] [27] and mutational effects [28] [29] [30] of proteins using evolutionary information contained in an multiple sequence alignment of a protein family. The statistical global pairwise entropy model used for protein inference accurately captures co-evolving sites within a protein which can be utilized to identify structural and functional important position using evolutionary couplings (EC) analysis, infer the protein structure, and predicted the effects of mutational changes (referred to as EVmutation).
In this work we present a novel formulation of the de-immunization problem that uses, for the first time to our knowledge, the maximum entropy model for protein design solving the inverse inference problem. Incorporating the maximum entropy model, as opposed to force-field based approaches such as FoldX 31 , has four distinct advantages: (i) The statistical model does not require a known structure or depend on the conditions in which the structure was measured.
(ii) It implicitly considers constraints on residues from interactions with ligands and other proteins, and (iii) models interactions between mutations rather than early filtering of deleterious singles. (iv) A de-immunization approach using the maxi-mum entropy model is likely to generate more viable structures as it minimizes potential damage to protein function at the same time as minimizing the immunogenicity of the biotherapeutic design. The latter can also be achieved by incorporating a force field, such as AMBER 32 , into the optimization process 21, 22 , which however complicates the de-immunization formulation.
As the frequencies of HLA alleles differ drastically between populations, the immunogenicity of the biotherapeutic might differ as well. It is thus imperative to design a biotherapeutic for a specific target population considering their HLA allele frequencies, as opposed to treating each HLA allele equally important during the design process, as previous methods have done. We therefore developed a new quantitative immunogenicity objective that considers the HLA allele distributions within different populations. The resulting de-immunization model does not require known structural information about the protein, summarizes functional and structural information that might not be captured by a structurebased model, and considers the varying HLA frequencies in different populations. We also demonstrate how the resulting bi-objective combinatorial optimization problem can be formulated in a concise manner and solved efficiently for relevant problem sizes with a newly developed distributed solving strategy.
An experimental validation of the resulting designs confirms that the algorithm can indeed lead to significantly reduced immunogenicity.
RESULTS

Formulation of the de-immunization problem
The problem of protein de-immunization can be described as identifying amino acid substitutions that reduce immunogenicity by removing T-cell epitopes while at the same time keeping the structure and function of the protein intact. We therefore define the problem of de-immunization as a bi-objective optimization problem. The first objective characterizes the immunogenicity of the target protein with re-spect to a set of HLA alleles by applying a start-of-the art, continuous immunogenicity prediction meth- More formally, we define the protein de-immunization problem as follows: Given a protein sequence S of length n and a set M i of possible alterations per position 1 ≤ i ≤ n. We seek a mutant S ′ of S with k alterations for which S ′ i ∈ M i ∀ 1 ≤ i ≤ n holds and that minimizes:
The model therefore optimizes the trade off between these two objectives and produces a set of Paretooptimal designs of the protein sequence.
As proof-of-principle, we tested the ability of the model to predict low immunogenic constructs of the C2 domain of Factor VIII as the domain is highly immunogenic and involved in the ADA development in hemophilia A patients when used therapeutically 35, 36 .
Accurate predictions of mutation effects using EVmutation
Evolutionary couplings computed from sequence alignments have been used successfully to predict the phenotypic effects of mutations [28] [29] [30] 37 , as well as the 3D structure shown in earlier work [23] [24] [25] [26] [27] . The ap-proach assigns an evolutionary statistical energy to any protein sequence that is hypothesized to correspond to the fitness of the molecule. The computation of the statistical energy of the protein and any changes to it after mutation is automatic and does not depend on computing or knowing the 3D structure. Therefore we reasoned that we could use this statistical model in a generative mode for design within the algorithmic de-immunization process.
As previous work on predicting the effect of mutations suggested that the model accuracy depends on the diversity of the sequence alignment and the ability to predict the 3D structure accurately 30 , we used the precision of the total epistatic constraints between residue pairs as an approximation of the model validity. Overall, 70 long-range evolutionary coupled residue pairs (ECs) have a probability of at least 90% of being significant and 65 of these (93% precision) are close in space (less than 5Å; Figure 1A ,
Supplementary material S1) in a 3D structure of Factor VIII's C2 domain (pdb: 3hny 38 ; Fig. 1B ).
To assess how well EVmutation can predict the effects of specific mutations compared to force-field methods, we used EVmutation and FoldX predictions in a multinomial and logistic regression to predict hemophilia A severity (severe, moderate, and mild) based on patient data collected from the Factor VIII variant database (http://www.factorviii-db.org, Supplementary Table S2 ). Since the severity of HA is directly correlated with instability and malfunctioning of Factor VIII, the prediction of disease severity can be seen as a proxy for functional and structural effect prediction. The multinomial regression model, using the change in statistical energy between mutant and wild type as independent variable, shows a moderate ability to predict the clinical outcome (F1-micro of 0.65 ± 0.09, F1-macro of 0.47 ± 0.07). Fig 1D) , but also yielded higher predictive power compared to its multinomial model (weighted AUC: 0.62 ± 0.11, weighted F1 0.58 ± 0.13).
Strong immunogenic region contains functional sites.
Initial prediction of epitopes using TEPITOPEpan 33 with the three most prevalent HLA alleles in the European population (accounting for 70% of the patients in Western Europe) resulted in 16 epitopes in 6
regions of the C2-domain of Factor VIII (UniProt: FA8_HUMAN). The region with the highest scoring immunogenicity (residues 2,312-2,340) had nine of the 16 predicted strong binding epitopes ( Fig. 2A and 2B), making it a prime candidate region for de-immunization mutation design. However there is evidence that this very region might be of high functional importance for the protein; The region is enriched for conserved co-variation of residues and contains a known membrane-binding motif 38 . Eight of the top ten evolutionary couplings involve residues in the high immunogenic region ( 
De-immunization of Factor VIII's C2 domain
We next used our bi-objective de-immunization model to design sequences of the identified highly immunogenic region resulting in 21 Pareto-optimal sequences with up to three simultaneous point mutations (Table 1 , Fig. 3 ). Although the model was set up to constrain sequence substitutions solely to the identified immunogenic region, the resulting fitness change was optimized based on the interactions with all sites in that protein domain. Even though none of the 21 designed sequences were predicted "fitter" than the wild-type, they were all close to the wild-type fitness. The computed fitness of 20 out of 21 designs resided in 95% percentile or higher when compared to the whole distribution of single, double, and triple mutations, suggesting that the protein would remain stable and functional. The sequence with the highest difference to wild-type fitness prediction (Design-11; V2313M, Y2324L, V2333E) was located in the 90% percentile and still close to WT fitness (reduction of 1.7%) and also had the maximal predicted reduction of immunogenicity (immunogenicity reduction of 45%) deleting eight out of nine epitopes of identified region. The nextbest triple mutant (L2321T, I2327L, V2333E) resulted in the deletion of eight epitopes with an immunogenicity reduction of 42% and a fitness reduction of 1.28%. force-field based modeling, such as FoldX 31 . As to distinguish the differences between FoldX and the employed statistical sequence model we predicted the mutation effects of the 21 designs with EVmutation and FoldX (Table 1) between the two prediction methods were Design-11 (V2313M, Y2324L, V2333E) and Design-3 (Y2324L, V2333E), both of which introduced a mutation at a membrane-binding site 38 . FoldX predicted these designs comparatively less deleterious than EVmutation. One explanation for this discrepancy is that it would be harder for force-field based methods to capture the membrane binding constraints unless they were in the structure used. 
Experimental validation
To test the designs, we synthesized overlapping 15-mer peptides containing the introduced mutations and their wild-type counterparts. The peptides maximally covered the predicted epitopes around the mutations of all designed constructs that contained one and two mutations (Supplementary Table S2 ). The affinity of these peptides to the three HLA alleles was measured at time zero and after 24 hours (Methods, Supplementary Table S3 and S4). We linearly combined the measured affinity scores across alleles for each peptide respectively to produce a score that summarizes the overall immunogenicity (Fig. 5A ). 
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DISCUSSION
This work introduced a novel method to reduce a protein's immunogenicity while maintaining its functionality requiring only sequence information of the target protein. The method uses a new immunogenicity objective that is, in contrast to previous approaches, accounting for relative epitope strength and integrates HLA allele frequency information of a target population. Since the HLA distribution can differ tremendously between populations this will influence the immunogenicity of a protein and hence Tcell epitopes that are prioritized during the de-immunization process.
The fact the highly immunogenic region, a prior identified during an in silico screening and independently described by others 19 , coincides with a highly evolutionary connected as well as functionally important region underlines the need for methods that are capable of incorporating functional and structural integrity prediction in the de-immunization process. The de-immunization model introduced demonstrates the power of such approaches; the predicted immunogenicity of the complete domain could be reduced by 45% without disrupting the fitness landscape extensively. Moreover, the observed highly significant correlations between measured and predicted immunogenicity both on individual peptide and (reconstructed) segment level affirmed that the underlying assumptions made by the model are sufficient to predict the influence of mutation in terms of immunogenicity.
In the particular case of this Factor VII domain, we found no advantage to structure and force-field base approaches to assessing the effect of clinical mutation classification; structure-based approaches may even be a disadvantage when structure information is incomplete (e.g., binding partners not present).
This suggests that sequence information may be sufficient for de-immunization design, and is consistent with the previous observation that sequences alignments can be used to identify constrained interacting residues across biomolecules as well as the effect of mutations 30, 39 . However, high-quality diverse sequence alignments are not always available.
In summary, we proposed a novel de-immunization model that integrates quantitative immunogenicity optimization with sequence-based fitness optimization and used the approach to design novel C2 domains of Factor VIII that can be further validated for clinical application using mouse models or T-cell proliferation assays based on PBMCs of HA patients. The approach will allow bioengineers to reliably explore the design space of the target protein to select promising candidates for experimental evaluation.
METHODS
Derivation of the immunogenicity objective
The first objective of the de-immunization model is an adaptation of the immunogenicity score introduced by Toussaint et al. for epitope selection in the context of in silico vaccine design and is defined as follows 34 :
with being a set of epitopes, ,ℎ the immunogenicity of epitope ∈ bound to HLA allele ℎ ∈ . It assumes that each epitope independently influences the immune response with respect to all considered HLA alleles. The contribution of an HLA allele ℎ ∈ is directly proportional to its probability ℎ of occurring within the target population .
Derivation of the protein fitness objective
The second objective is a evolutionary statistical energy of sequences computed by a pairwise maximum entropy model of protein families. Under these family-specific models, the probability for a protein sequence (X 1 , ..., X n ) of length is defined as
where the pair coupling parameters J ij (X i , X j ) describe evolutionary co-constraints on the amino acid configuration of residue pairs i and j for all amino acids and the parameters h i (X i ) corresponds to single-site amino acid constraints. The partition function is a global normalization factor summing over all possible amino acid sequences of length n 23, 24 . The parameters J ij and h i are inferred from a protein family sequence alignment using an iterative approximate maximum likelihood inference scheme (pseudolikelihood maximization) under l 2 -regularization to prevent overfitting. Given an inferred probability model for a family, the statistical energy − ( ) can be used to quantify the fitness of specific sequences. Recent work has demonstrated that changes of E(X) quantitatively correspond to the experimental phenotypic consequences of mutations, including effects on protein stability and organismal growth 30 . In order to maintain protein function while minimizing immunogenicity, the second objective function is defined as the minimization of − ( ).
Evolutionary coupling (EC) strength between pairs of positions i and j is computed using the Frobenius norms of the matrices J ij with subsequent correction for finite sampling and phylogenetic effects (average product correction) 26 . The evolutionary couplings are predictive of residue proximity in many protein families, and the cumulative score of one position to all others (EC enrichment score) is indicative of functionally and structurally important positions 26 .
Derivation of the integer linear program representation of the de-immunization model
We (Table 2 O2).
The immunogenicity objective, in contrast to the problem formulation of Toussaint et al., in which the immunogenicity of each candidate epitope ∈ could be pre-calculated, does not have an easy ILP representation. It has to directly incorporate prediction methods to approximate the immunogenicity of the current mutant ′ . Therefore, we use TEPITOPEpan 33 as internal prediction engine since it has been demonstrated to have good predictive power and can be easily integrated into the ILP framework. More advanced, machine learning-based prediction models cannot readily be integrated into the problem formulation. With linear (matrix-based) methods, the integration is possible by scoring each peptide generated with a sliding window of width for each allele ℎ ∈ independently by summing over TEPITOPEpan's position specific scoring matrix ℎ, , → ℝ ≥0 for amino acid ∈ + at position + with ∈ 1. . ( − ) and ∈ {0. . ( − 1)}. To only consider predicted binding epitopes, the binding threshold ℎ of each HLA allele ℎ ∈ is subtracted from the sum score of an epitope and the maximum of 0 and the cumulative score is taken. The sum of all epitope scores for a particular allele ℎ ∈ is than weighted by its population probability ℎ . To make the prediction scores comparable across HLA alleles, the position specific scoring matrices of TEPITOPEpan were z-score normalized and the binding thresholds adjusted accordingly. The final immunogenicity score consists of the sum of all allele-wise weighted sums (Table 2, O1). Table 2 : Bi-objective integer linear program formulation of the de-immunization problem.
Definition:
Objectives:
Constraints:
To construct a consistent model, three constraints have to be introduced guaranteeing that only one amino acid per position is selected (Table 2, C1) and that only pairwise interactions are considered for selected variants (i.e., , , , , = 1 ↔ , = 1 ⋀ , = 1, see Table 2 C2 and C3). Constraints C2 and C3 can be further relaxed by dividing the pairwise fitness values into positive and negative sets 40 , which is done in practice but disregarded here for ease of presentation. To be able to restrict the mutant to a specific number of introduced variations, constraint C4 limits the number of deviating amino acids to the wild type sequence . A detailed formulation of the complete optimization problem can be found in Supplementary Table S6 .
Pre-processing
To reduce the search space, a filtering approach based on position specific amino acid appearance frequency , i.e. conservation can be applied. Only amino acids at position ∈ {1. . } exceeding a certain frequency threshold are considered as possible substitution at a site. Hence, the set of possible substitutions per position is defined as ∶= ∈ ( ) ≥ }. The wild type amino acid is additionally added if it does not exceed the frequency threshold. This filtering is based on the assumption that variants that are not or infrequently observed are harmful due to either destabilizing effects, reduction of function, or intervening effects with interaction partners.
Solving a bi-objective integer program
Special strategies have to be applied to solve a BOMILP. Popular methods to solve discrete multiobjective problems include the -constraint 41 , perpendicular search 42 , and the augmented weighted Chebychev method 43 . All have their own limitations. The recently published rectangle splitting approach tries to overcome these 44, 45 . For solving the de-immunization problem, we developed a parallel two-phase version of the rectangle-splitting approach that can exploit the parallel nature of the algorithm and can effectively utilize modern distributed computing resources. In the following we sketch the newly developed two-phase approach.
First we introduce necessary notations and concepts (adopted from Boland et. al.) . 
These operations will be denoted as = lex min , 1 :
in parallel (Fig. 6A) . Then, the search space within ( , ) is evenly constraint based on boundary conditions enforced w.l.o.g. on 1 (Fig. 6B) . The boundaries are calculated for a predefined number of constraints with:
Each section of the separated search space can be independently searched by solving z i = lex min x∈X z 1 x ,z 2 x : z x ∈R (τ i z 1 ,z 2 T ,z B ) and the resulting new nondominated points can be used as initial approximation of the Pareto front. The found nondominated points might contain duplicates and also might not resemble the complete Pareto front. Therefore, it is necessary to perform a refinement of the Pareto front to find the remaining nondominated points. To this end, the nondominated points are sorted in nondecreasing order such that 1 1 ≤ 1 2 ≤ ⋯ ≤ 1 . Each consecutive pair of points spans a search rectangle ( , ) with ≤ . These rectangles can now be searched in parallel by the rectangle-splitting algorithm (Fig. 6C) . The search rectangles are split in half. First, the bottom half is searched by solv- accordingly proofs that the area does not contain further nondominated points. The search procedure is carried out until the complete search space has been explored.
Inference of the maximum entropy sequence model
Multiple sequence alignments (MSA), created by JackHMMER 46 , were used for the inference of the maximum entropy models of the Factor VIII C2-domain (residues 2,188-2,345 of FA8_HUMAN, Supplementary material S1). To optimize residue coverage and MSA diversity, the alignment was created using five search iterations at an E-value threshold of 10 -20 . Sequences with 70% or more gaps and columns with over 50% gaps were excluded from subsequent statistical inference. To reduce the influence of sampling bias in the inference step, sequences were clustered at a 90% identity threshold (theta 0.9), and reweighted by the inverse of the number of cluster members. The parameters of the pairwise maximum entropy model and evolutionary couplings were then inferred using EVfold PLM 47 with pseudolikelihood maximization 48 (Supplementary material S1). Substitution effects were derived by calculating the difference between the wild-type and the mutant statistical energy 30 . The validity of the maximum entropy model was verified by using the precision of the inferred top evolutionary couplings (ECs) between residue pairs compared to an existing 3D structure. To identify the top ECs a Gaussian-lognormal mixture model was inferred based on the overall score distribution 27 and the ECs within the tail of the distribution (ECs with a probability ≥ 0.90 of belonging to the lognormal) were used for model quality assessment 27 .
Hemophilia a severity data and regression analysis
Single point mutation data with known patient severity status was extracted from the Factor VIII variant database (http://www.factorviii-db.org). The data was filtered for mutations residing within the C2 domain, which resulted in 40 data points in total (Supplementary Table S5 ). The severity status of each patient was determined based on a one-stage Factor VIII:C and categorized into three classes -severe (<1%), moderate (1-5%), and mild (>5%). The data points were unevenly distributed across the classes with 15 severe, 8 moderate, and 17 mild cases.
To train and validate the multinomial and logistic regression models, the data was randomly divided into training and test set (70:30%-split) in a stratified manner. This process was repeated two hundred times and the prediction performance averaged over the runs.
Experimental design
In order to experimentally verify our in silico predictions for Factor VIII, we utilized the commercial REVEAL HLA-Peptide binding assay of ProImmune (www.proimmune.com). In addition to binding, stabilities of HLA-peptide complexes were also investigated. Peptides were synthesized using the PEP screen custom library synthesis method, yielding high purity peptides for experimental analysis. HLApeptide binding was assessed for the three HLA-DRB1 alleles used in this study (DRB1*1501, DRB1*0301 and DRB1*0701). In short, the method compares the affinity of the studied peptide to the affinity of a high-affinity control peptide. Each peptide is then scored for binding to a certain HLA molecule relative to the score of the control peptide, and reported as the percentage of the signal generated by the control peptide. In order to assess the stability of binding, the amount of bound peptide is measured at time zero and after 24 hours. From these measurements a stability index is calculated.
Implementation
The two-phase rectangle-splitting solver was implemented in Python 2.7 using the CPLEX package, Numpy 1.4, and Polygon 2.0.6 package. CPLEX 12.6 was used as backend to solve the BOMILP models.
Structure-based fitness prediction for validation purposes of the de-immunized Factor VIII C2 domain constructs were performed with FoldX 31 using default settings for the obtained mutations. TEPITOPEpan 1.0 was used for epitope prediction.
Statistical analysis
The multinomial and logistic models were fit and evaluated using Scikit-learn 0.18 49 . The statistical analysis was conducted with R 3.0.2. Statistical significance was considered at = 0.05. The specific statistical tests used are indicated in the figures or in the results section.
Code availability
The solver implementation, the ILP model in AMPL format, and the instances solved are available at https://github.com/FRED-2/EVdeimmunization released under a 3-claus BSD license.
ADDITIONAL INFORMATION
Material S1: The long-range evolutionary couplings of Factor VII C2 domain, and the multiple sequence alignments used for model inference. 
